Literature DB >> 20487372

Imbalance of peroxisome proliferator-activated receptor gamma and adiponectin predisposes Kawasaki disease patients to developing atherosclerosis.

Hideo Fukunaga1, Masahiko Kishiro, Katsumi Akimoto, Yoshikazu Ohtsuka, Satoru Nagata, Toshiaki Shimizu.   

Abstract

BACKGROUND: It remains controversial whether Kawasaki disease (KD) is a risk factor for the onset of atherosclerosis. An imbalance of peroxisome proliferator-activated receptor γ (PPARγ) and adiponectin appears to play a role in the onset of atherosclerosis in adults, and we therefore examined PPARγ mRNA expression and adiponectin profiles in the peripheral white blood cells obtained from KD patients.
METHODS: A total of 50 subjects were studied: nine patients with acute KD, 20 patients with convalescent KD, and 21 age-matched controls. The gene expression of PPARγ, monocyte chemoattractant protein-1, and CC chemokine receptor 2 present in the blood were quantified. The relative gene expression, adiponectin levels, and the three adiponectin isoforms were compared among the subjects.
RESULTS: The abundance of PPARγ and CC chemokine receptor 2 mRNA was significantly increased in convalescent KD patients. The monocyte chemoattractant protein-1 level was also increased in convalescent KD patients. The level of high-molecular-weight adiponectin was significantly lower in convalescent patients compared to controls. The PPARγ transcription levels negatively correlated with apolipoprotein A-I levels in acute KD patients.
CONCLUSIONS: The transcript abundance of PPARγ and low levels of high-molecular-weight adiponectin in KD patients may have important clinical implications on the development of premature atherosclerosis. Because the potential risk for developing atherosclerosis has not yet been verified, long-term observation is important, even in convalescent KD patients without coronary artery lesions.
© 2010 The Authors. Pediatrics International © 2010 Japan Pediatric Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20487372     DOI: 10.1111/j.1442-200X.2010.03160.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  5 in total

1.  Hypercoagulation and elevation of blood triglycerides are characteristics of Kawasaki disease.

Authors:  Xi Chen; Zhen-Wen Zhao; Lin Li; Xue-Jun Chen; Hui Xu; Jin-Tu Lou; Lin-Jie Li; Li-Zhong Du; Chun-Hong Xie
Journal:  Lipids Health Dis       Date:  2015-12-30       Impact factor: 3.876

2.  Circulating adipokines are associated with Kawasaki disease.

Authors:  Xin-Yan Zhang; Ting-Ting Yang; Xiu-Fen Hu; Yu Wen; Feng Fang; Hui-Ling Lu
Journal:  Pediatr Rheumatol Online J       Date:  2018-05-08       Impact factor: 3.054

3.  The radial augmentation index in children with Kawasaki disease without acute coronary artery lesions during the convalescent period.

Authors:  Jianbo Zheng; Tsuneyuki Nakamura; Na Lu; Kaori Hori; Masato Oguri; Masaru Sakurai; Masao Ishizaki
Journal:  Ther Clin Risk Manag       Date:  2019-06-12       Impact factor: 2.423

4.  The role of peroxisome proliferator-activated receptor gamma and adiponectin in children with Kawasaki disease.

Authors:  Ji-Yong Zhang; Hong Peng; Si-Tang Gong; Yong-Mei Zeng; Miao Huang; Pei-Hui Liu; Li-Ting Wang; Guo-Qing Dong
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

5.  Adipocytokine profile in children with Kawasaki disease at a mean follow-up period of 5.5 years: A study from North India.

Authors:  Dibya Lochan Praharaj; Amit Rawat; Anju Gupta; Kanika Arora; Rakesh Kumar Pilania; Sagar Bhattad; Surjit Singh
Journal:  World J Clin Pediatr       Date:  2022-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.